Medications for Weight Loss: The New Satiety Hormones

Scripps Health

K. Fujioka

The GOOD and the BAD Side of GLP-1s and What to Do If You Get Caught…

Endocrinology 2024 Year in Review

Weightloss in Menopause

Susan Brian

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

Tirzepatide Updates

Diana Isaacs

When It Is Irritable Bowel Syndrome and When It May Be Something Els…

Ludeman Family Center for Women’s Health Research

J. Christie

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

Tirzepatide for Type 2 Diabetes

Diana Isaacs

Biomarkers in Gaucher Disease: An Evolution

The France Foundation

P. Kishnani

Obesity: New Understanding and Treatments

Norman Lepor

ACC 2024 Insights: A Plant-Based Diet

ACC 2024 Insights

N. Barnard

Heart Failure in Women: 2025 Update

Scripps Health

M. Kittleson

Wegovy 2024 Updates

Susan Brian